Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Priority Technology | PRTH | Sep 19, 2024 | 6.66 | +4.88 |
Privia Health Group | PRVA | Sep 19, 2024 | 19.44 | +1.94 |
Pro-Dex | PDEX | Sep 19, 2024 | 27.62 | +8.31 |
ProAssurance | PRA | Sep 19, 2024 | 13.50 | +2.04 |
Procaps Group | PROC | Sep 19, 2024 | 1.80 | -0.55 |
Procept BioRobotics | PRCT | Sep 19, 2024 | 82.79 | -0.22 |
Processa Pharmaceuticals | PCSA | Sep 19, 2024 | 1.37 | -3.52 |
Procore Technologies | PCOR | Sep 19, 2024 | 60.04 | +5.59 |
Procter & Gamble | PG | Sep 19, 2024 | 171.54 | -1.37 |
Professional Diversity Network | IPDN | Sep 19, 2024 | 0.43 | -5.09 |
Proficient Auto Logistics | PAL | Sep 19, 2024 | 17.29 | +0.23 |
Profire Energy | PFIE | Sep 19, 2024 | 1.52 | +3.40 |
Profound Medical | PROF | Sep 19, 2024 | 7.84 | +4.26 |
ProFrac A | ACDC | Sep 19, 2024 | 6.50 | +1.72 |
PROG | PRG | Sep 19, 2024 | 48.82 | +3.10 |
Progress Software | PRGS | Sep 19, 2024 | 57.67 | +0.26 |
Progressive | PGR | Sep 19, 2024 | 255.30 | -0.92 |
Progyny | PGNY | Sep 19, 2024 | 16.46 | -32.65 |
Project Energy Reimagined Acquisition Unit | PEGRU | Sep 19, 2024 | 11.10 | 0.00 |
ProKidney | PROK | Sep 19, 2024 | 2.39 | 0.00 |
Prologis | PLD | Sep 19, 2024 | 128.50 | +1.17 |
ProMIS Neurosciences | PMN | Sep 19, 2024 | 1.23 | -0.81 |
PropertyGuru | PGRU | Sep 19, 2024 | 6.61 | +0.30 |
ProPetro | PUMP | Sep 19, 2024 | 8.23 | +2.36 |
ProPhase Labs | PRPH | Sep 19, 2024 | 2.51 | +2.45 |
ProQR Therapeutics | PRQR | Sep 19, 2024 | 1.78 | -1.11 |
PROS | PRO | Sep 19, 2024 | 19.21 | +7.86 |
ProShares Bitcoin Strategy ETF | BITO | Sep 19, 2024 | 19.17 | +5.39 |
Proshares Ultra FTSE Europe | UPV | Sep 19, 2024 | 69.16 | +3.44 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Sep 19, 2024 | 70.79 | -2.32 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.